October 22 2024 - Starboard wants to hold Pfizer leadership 'accountable' for overpaid M&A deals, poor return on R&D investment

Starboard wants to hold Pfizer leadership 'accountable' for overpaid M&A deals, poor return on R&D investment
Moderna’s norovirus vaccine mRNA-1403 shows potential in Phase I/II trial
Health insurance giants restart merger talks
Otsuka eyes early filing of IgAN drug after phase 3 readout
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*